Proteomic Profiles in Patients with Thrombosis Due to COVID-19 Are Distinct from Non-COVID-19 Thrombosis

BACKGROUND. COVID-19 is a prothrombotic disease, characterized by endotheliopathy, hypercoagulability, and thromboembolic complications. We hypothesized that the pathogenesis of thromboembolism associated with COVID-19 might differ from thromboembolism in patients without COVID-19. In this study, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Madeeva, Daria V, Borges, Kelly, Shallow, Marcus, Juthani, Prerak V, Wang, Stephen Y, Gupta, Akash, Chun, Hyung J., Lee, Alfred Ian, Pine, Alexander B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology. Published by Elsevier Inc. 2021
Materias:
331.Thrombosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701622/
http://dx.doi.org/10.1182/blood-2021-153959

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701622/
http://dx.doi.org/10.1182/blood-2021-153959

Ejemplares similares